Dr. Patel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1126 N Church St
Ste 203
Greensboro, NC 27401Phone+1 336-235-0944Fax+1 336-235-0947
Summary
- Dr. Niraj Patel is an allergist/immunologist at Duke University Medical Center. He received his medical degree from University of Louisville School of Medicine and completed fellowships in both Allergy and Immunology and Pediatric Infectious Diseases at Baylor College of Medicine. He has been in practice 17 years. He specializes in immunodeficiencies in pediatrics and adults, unexplained fevers, secondary immunodeficiencies, immune dysregulation, hereditary angioedema, and clinical & laboratory immunology. He has more than 30 publications and over 500 citings.
Education & Training
Baylor College of MedicineFellowship, Allergy and Immunology, 2007 - 2009- Baylor College of MedicineFellowship, Pediatric Infectious Diseases, 2003 - 2006
University of Louisville School of MedicineResidency, Pediatrics, 2000 - 2003- University of Louisville School of MedicineClass of 2000
Certifications & Licensure
NC State Medical License 2009 - 2025
GA State Medical License 2019 - 2023- GA State Medical License 2021 - 2023
TX State Medical License 2006 - 2009- American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- Distinguished Service Award American College of Allergy, Asthma, and Immunology, 2021
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2010-2013
Clinical Trials
- Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID) Start of enrollment: 2017 Feb 01
Publications & Presentations
PubMed
- 73 citationsCharacterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutationsTiziana Lorenzini, Manfred Fliegauf, Nils Klammer, Natalie Frede, Michele Proietti
The Journal of Allergy and Clinical Immunology. 2020-04-09 - 14 citationsSubcutaneous Immunoglobulin Replacement Therapy with Hizentra® is Safe and Effective in Children Less Than 5 Years of AgeNiraj C. Patel, Joel L. Gallagher, Hans D. Ochs, Thomas Prescott Atkinson, Justin T. Wahlstrom
Journal of Clinical Immunology. 2015-09-04 - 170 citationsJakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations.Lisa R. Forbes, Tiphanie P. Vogel, Megan A. Cooper, Johana Castro-Wagner, Edith Schussler
The Journal of Allergy and Clinical Immunology. 2018-11-01
Press Mentions
James Tracy Installed as ACAAI PresidentOctober 27th, 2024- Gargling Salt Water Significantly Cuts COVID-19 Hospitalization RiskNovember 9th, 2023
ACAAI COVID-19 Task Force Members Available to Discuss Allergic Reactions to mRNA VaccinesDecember 21st, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
